Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 4:13 pm Sale | 2025-03-31 | 13G | InMed Pharmaceuticals Inc. INM | AdvisorShares Trust | 0 0.000% | -1,833 (Position Closed) | Filing History |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 36,135 4.900% | 34,823 (+2653.29%) | Filing History |
| 2024-12-18 08:05 am Purchase | 2024-12-13 | 13G | InMed Pharmaceuticals Inc. INM | YA II PN, Ltd. | 80,372 9.990% | 80,372 (New Position) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 34,816 4.990% | 33,300 (+2197.27%) | Filing History |
| 2024-11-12 1:44 pm Purchase | 2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM | AdvisorShares Trust | 1,833 8.770% | 1,833 (New Position) | Filing History |
| 2024-02-14 2:28 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 1,516 9.990% | 1,101 (+265.88%) | Filing History |
| 2024-01-03 5:43 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 1,312 11.000% | 1,312 (New Position) | Filing History |
| 2023-02-14 12:58 pm Purchase | 2022-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 414 9.990% | 414 (New Position) | Filing History |
| 2022-02-04 3:29 pm Purchase | 2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Hudson Bay Capital Management LP | 56 3.810% | 12 (+25.99%) | Filing History |
| 2021-02-09 4:05 pm Purchase | 2020-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Hudson Bay Capital Management LP | 44 5.970% | 44 (New Position) | Filing History |
| 2021-01-20 11:11 am Unchanged | 2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Empery Asset Management, LP | 44 4.990% | 0 (Unchanged) | Filing History |
| 2020-11-18 10:08 am Purchase | 2020-11-12 | 13G | InMed Pharmaceuticals Inc. INM | Empery Asset Management, LP | 44 6.350% | 44 (New Position) | Filing History |